Anti-Human IL17A Recombinant Antibody(Bimekizumab)
-
产品编号
YR1328
-
别名
科研级 Bimekizumab ( 比美吉珠单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Bimekizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Bimekizumab ( 比美吉珠单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Bimekizumab |
| Catalog Number | YR1328 |
| Molecular Name | Bimekizumab |
| CAS Number | 1418205-77-2 |
| Target | IL17A[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Bimekizumab (INN) is a humanized anti-IL17A and IL-17F monoclonal antibody that is being investigated for ankylosing spondylitis, psoriatic arthritis, and psoriasis. This drug is being developed by Belgian pharmaceutical UCB. As of 2018, bimekizumab is undergoing Phase III trials. |
| Application | ELISA, FCM, IP, FuncS, IF, Neut |
| Remarks | This product is for research use only. |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5栋
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 8:30-18:00 -
-
0
-
